| Value | Category | Cases | |
|---|---|---|---|
| 1 | Oral administration | 9 |
37.5%
|
| 2 | Intravenous injection | 0 |
0%
|
| 3 | Topical Application | 0 |
0%
|
| 4 | Intramuscular injection | 15 |
62.5%
|
| 5 | Per Vagina | 0 |
0%
|
| Sysmiss | 5964 |